Cargando…
Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related deaths in the United States. The 5-year survival rates are poor with traditional therapy alone. New scientific advances in technology involving the human genome, including diagnostic tools to inform on tumor-derived acquired (somatic) mutations that...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881738/ https://www.ncbi.nlm.nih.gov/pubmed/36727019 http://dx.doi.org/10.6004/jadpro.2022.13.8.5 |